ライフサイエンスコーパス: die from

1 1,244 children (3% of sample) died from 1994 to 2008.

2 ventricular arrhythmias (11% versus 1%), and die from a cardiac cause (2% versus 0%) than family memb

3 s alpha-syn to accumulate; such cells likely die from a combination of ER stress and excessive accumu

4 increased mortality risk if the sibling had died from a discordant main cause, which may strengthen

5 One patient died from a laryngeal attack 25 days after last study dr

6 verage follow-up 13.9 years), of whom 29,076 died from a natural cause during follow-up.

7 was isolated from the brain of a patient who died from a rapidly progressing demyelinating disease kn

8 om one patient in the chemotherapy group who died from a secondary tumour (head and neck anaplastic e

9 virus was first isolated from a patient who died from a severe respiratory illness in June, 2012, in

10 s three (2%) patients in the docetaxel group died from a treatment-related adverse event.

11 Four children died from a treatment-related toxic effect; one (<1%) of

12 tivated-caspase 3, suggesting that they were dying from a non-apoptotic mechanism.

13 t, and for the last 8 y the number of plants dying from a sudden wilt disease has increased, leading

14 with pancreatitis that were depleted of DCs died from acinar cell death within 4 days.

15 H1N1 influenza-positive donors, one of whom died from active H1N1 infection.

16 reasons for hospital admission of those who died from acute myocardial infarction.

17 btained from a Saudi Arabian businessman who died from acute respiratory failure.

18 rajectory was observed only for subjects who died from advanced dementia (67.9% of these subjects had

19 Nine patients died from adverse events; five of these deaths were judg

20 Four (2%) patients died from adverse events; one (pulmonary embolism in tre

21 d become newly infected, and 1.6 million had died from AIDS-related causes.

22 We estimate that, of people dying from AIDS between 2010 and 2030, most will have in

23 artery disease did not increase the risk to die from all or vascular causes.

24 ng the 76 186 person-years of follow-up, 748 died from all causes.

25 ecome clear that most septic patients do not die from an overwhelming proinflammatory immune response

26 Mice died from an acute lymphocytic pneumonitis in which T an

27 herapy group and 168 (28%) in the CABG group died from an adjudicated cardiovascular cause (hazard ra

28 nd bronchopulmonary LNs of 11 nonsmokers who died from an asthma exacerbation (fatal asthma [FA]) in

29 One patient died from an intracranial haemorrhage that was judged by

30 One patient died from an overwhelming adenoviral infection before re

31 en June 27, 2007, and June 30, 2010; one man died from an unrelated cause (pneumonia) 3 months after

32 oma or an early treatment complication and 6 died from another cause; among those receiving radiation

33 rgan donor, the PHS donor was younger, male, died from anoxia, more likely to be HCV and antibody rea

34 on control parents who had not had offspring die from any sudden cause during the study period.

35 NP versus 78 patients (27%) who increased it died from any cause (adjusted hazard ratio=0.53; 95% con

36 Fewer women in the oestrogen group died from any cause after a breast cancer diagnosis (30

37 er a median of 15.8 years, 1246 patients had died from any cause and 12 had died from colorectal canc

38 m, 261 (0.7%) died by suicide and 832 (2.2%) died from any cause within 12 months.

39 y outcome was the proportion of patients who died from any cause within 28 days after inclusion.

40 dian follow-up of 2.9 yr, 453 (41%) patients died from any cause, 215 (20%) had a cardiovascular even

41 ants reached the primary end point and 49.1% died from any cause.

42 a-VEGF (D/R) or (D/-) groups, animals mainly died from arterial thromboembolisms and in the alpha-VEG

43 tin treatment, experienced ASCVD events, and died from ASCVD-related or non-ASCVD-related causes base

44 In addition, C/EBPgamma-deficient newborns die from atelectasis and respiratory failure, which can

45 HDAC3-deficient mice died from autoimmunity by 4-6 weeks of age; however, inj

46 After 3 patients died from bacterial infections, treatment with vancomyci

47 In the oestrogen group, fewer women died from breast cancer (six deaths, 0.009% per year) co

48 rapy and four of 40 assigned to radiotherapy died from breast cancer.

49 erienced SBCE, 627 had a recurrence, and 237 died from breast cancer.

50 ed for an average of 9 years during which 75 died from breast cancer.

51 ng a 15-year follow-up, 121 patients (12.4%) died from breast cancer.

52 Ninety patients (12.8%) died from breast cancer.

53 2DM) are at a greater risk of developing and dying from breast cancer than women without T2DM.

54 CBC is associated with an increased risk of dying from breast cancer throughout a long period of fol

55 The hazard of dying from breast cancer was especially high for women w

56 is the major risk factor for developing and dying from breast cancer.

57 None of the patients died from Burkitt's lymphoma.

58 Every year, almost 100 000 children die from cancer before the age of 15 years, more than 90

59 er burden, with poorer people more likely to die from cancer before the age of 70 years than those wh

60 ATM-null mice exhibit A-T disease but they die from cancer before the neurological symptoms are man

61 Most patients who die from cancer succumb to treatment-refractory advanced

62 ent, data were gathered for 308 patients who died from cancer (147 in LCP-I programme wards and 161 i

63 Most patients died from cancer (n = 20).

64 8 million people died from cancer in 2010, 38% more than two decades ago;

65 or each ward, we identified all patients who died from cancer in the 3 months before randomisation (p

66 ive cardiovascular events and a major number dies from cancer.

67 ients with cancer according to their risk of dying from cancer relative to overall mortality.

68 nificantly associated with a lower hazard of dying from cancer, circulatory disease, and respiratory

69 increased mortality in cohabitees of people dying from cancer.

70 y being linked to the risk of developing and dying from cancer.

71 ted: one patient in the FGFR2(non-mut) group died from cardiac arrest with contributing reason of pul

72 red in four (3%) patients: one (<1%) patient died from cardiac death, one (<1%) patient had periproce

73 ) of 31 patients with successful implant had died from cardiac reasons, with no cardiac deaths occurr

74 death in the rivaroxaban group; this patient died from cardiogenic shock on day 50 after a type A aor

75 vascular outcomes, even though most patients die from cardiovascular causes despite the beneficial ef

76 A higher proportion of patients with NAFLD die from cardiovascular disorders than patients with ALD

77 atients (49.3%) in the medical-therapy group died from cardiovascular causes (hazard ratio, 0.79; 95%

78 , 558 (13.3%) and 693 (16.5%), respectively, died from cardiovascular causes (hazard ratio, 0.80; 95%

79 Fewer patients died from cardiovascular causes in the liraglutide group

80 son-years of follow-up, 77 patients died; 35 died from cardiovascular causes, of which 15 were sudden

81 RD developed in 51 patients, and 19 patients died from cardiovascular causes.

82 p, 81 (12%) patients died, of which 38 (47%) died from cardiovascular causes.

83 RD developed in 43 patients, and 27 patients died from cardiovascular causes; in the placebo group, E

84 One control died from cardiovascular collapse.

85 The unadjusted proportion of patients who died from cardiovascular disease increased as eGFR decre

86 total of 4,952 men died, of which 1,637 men died from cardiovascular diseases (CVD), 2,122 from canc

87 lity of 30% for these patients, the majority dying from cardiovascular causes.

88 ts with CKD seemed to be at greater risk for dying from cardiovascular disease (CVD) than reaching ES

89 entiated prostate cancer were more likely to die from causes other than their disease.

90 ted from patients 19 to 104 years of age who died from causes other than cardiovascular diseases.

91 DNA, organ specimens from 49 individuals who died from causes other than tuberculosis were studied by

92 of patients with stage 2 disease and an SVR died from causes secondary to HCC (2.0%) compared with t

93 n sub-Saharan Africa continue to acquire and die from cerebral malaria, despite efforts to control or

94 Blantyre, Malawi, on pediatric patients who died from cerebral malaria and controls.

95 reased brain volume was seen in children who died from cerebral malaria but was uncommon in those who

96 rocyte sequestration in patients with or who died from cerebral malaria.

97 Two patients died from chronic GVHD or unrecognized drug rash with eo

98 ive, nationwide analysis of all patients who died from cirrhosis in England between 2013 and 2015, wh

99 a mean follow-up of 14.7 years, 114 subjects died from cirrhosis; 33 of them from viral hepatitis B (

100 In 18 Malawian children who died from clinically defined CM, we studied the intensit

101 eated with buprenorphine and morphine do not die from clostridial myonecrosis.

102 Thirteen children had MR and died from CM.

103 patients had died from any cause and 12 had died from colorectal cancer.

104 versus 996 individuals in the control group died from colorectal cancer.

105 and drought-tolerant species, and trees that died from competition.

106 One child died from complications at age 17 months.

107 patients were lost to follow-up, 4 patients died from complications of cardiac surgery, and 2 patien

108 One patient died from complications of IMN and one died from complic

109 tient died from complications of IMN and one died from complications of the haematological disease.

110 0-2 500 000 copies/mL) received cidofovir; 1 died from complications relating to adenovirus and concu

111 ibe had a non-fatal myocardial infarction or died from coronary heart disease (213 [4.6%] vs 230 [5.0

112 5 y of follow-up, 329 men died from CVD, 148 died from coronary heart disease (CHD), and 72 men died

113 g-positive patient, who defaulted from care, died from cryptococcal meningitis (CM).

114 ual numbers of people who are developing and dying from cryptococcal meningitis.

115 In comparison, the predicted risk of dying from CT-induced cancer was 0.1% (five of 8057, P <

116 During 25 y of follow-up, 329 men died from CVD, 148 died from coronary heart disease (CHD

117 Forty-five participants died from CVD.

118 During the follow-up, 556 participants died from CVD.

119 1 killer of women; only 11% knew a woman who died from CVD.

120 HIV-infected CD4(+) T cells die from direct virus-induced apoptosis and CD8 T-cell-m

121 A single sham-vaccinated macaque died from disease due to EBOV infection.

122 had had rapid neurologic deterioration, had died from disease progression.

123 s and statistically significantly more males died from disease-related causes.

124 at mice intoxicated orally with ricin likely die from distributive shock.

125 1 day (>1 day vs. 1 day, P=0.01), those who died from distributive (vasodilated) shock (P<0.001), an

126 reatment; one patient in the gefitinib group died from drug-related hepatic and renal failure.

127 tients who underwent RFA of BE, less than 1% died from EAC.

128 Although five of eight patients died from early disease progression, we observed that lo

129 Five patients died from early progression (n = 2), sepsis (1) or after

130 A 9-month-old infant died from Ebola virus (EBOV) disease with unknown epidem

131 of the patients required transplantation or died from end-stage liver disease.

132 Four patients (22%) died from endocarditis or complications to treatment, 2

133 Few people died from epilepsy-related causes.

134 Out of 171 patients identified, 2 had died from esophageal carcinoma.

135 Of those who died from external causes, 75.2% had comorbid psychiatri

136 sians had found excess vodka use among those dying from external causes (accident, suicide, violence)

137 Globally, trees are increasingly dying from extreme drought, a trend that is expected to

138 Two patients died from from myocardial infarction potentially related

139 nemia in the course of his EBV infection and died from fulminant gram-positive bacterial sepsis.

140 One patient was initially thought to have died from grade 5 radiation pneumonitis during the study

141 Patients who died from haematological cancer (PRs 0.46-0.52), who wer

142 of patients with stage 1 disease and an SVR died from HCC (2.9%), compared with those without an SVR

143 g the 16 screen-detected HCC cases, only two died from HCC, indicating a favorable survival.

144 atients expressed worry about developing and dying from HCC, but nearly half (49.9%) of patients repo

145 ull sample died during follow-up, and 22 152 died from heart disease.

146 Three patients died from heart failure within the first week of life.

147 group were hospitalized for heart failure or died from heart failure, as compared with 55 in the plac

148 severe pressure overload all Erbin(-/-) mice died from heart failure.

149 ity and residential addresses of persons who died from heat exposure in 2,081 census block groups.

150 ity and residential addresses of persons who died from heat exposure in 2,081 census block groups.

151 randomly assigned to ABVD alone, 6 patients died from Hodgkin's lymphoma or an early treatment compl

152 died (3 with disease progression, 1 of whom died from Hodgkin's lymphoma); there had been 20 instanc

153 90(ko/ko) mice exhibit early vision loss and die from hydrocephalus.

154 related to cancer (7.2%); one patient (0.6%) died from incidentally detected medullary thyroid cancer

155 e find that mated females are more likely to die from infection, suffer higher pathogen burdens, and

156 Although 2 patients died from infection, 3 recovered and experienced brief r

157 one vaccinated animal and the control animal died from infection.

158 f treatment; one patient receiving sorafenib died from infectious colitis while on treatment and four

159 One patient died from influenza B encephalitis during an endemic out

160 decades of life, more individuals in the USA die from injuries and violence than from any other cause

161 One patient died from intracranial bleeding after relapse.

162 onors were significantly more likely to have died from intracranial hemorrhage than were all other de

163 Among all people who died from ischemic heart disease or cancer, schizophreni

164 have been saved for each exposed worker who died from ischemic heart disease.

165 osed with the disease, and about 49,000 will die from it.

166 o be diagnosed with colorectal cancer and to die from it.

167 tuberculosis in 2013 and 1.5 million people died from it.

168 Mice homozygous for the mutation died from kidney failure within 72 hours after birth.

169 searcher with hereditary hemochromatosis who died from laboratory-acquired plague.

170 -positive blood cultures were more likely to die from late infection.

171 expressing D816V or D816Y KIT, respectively, died from leukemia within 9 months, whereas no control m

172 an coinfected women were much less likely to die from liver disease, as compared to Caucasians and Hi

173 eas a higher proportion of patients with ALD die from liver disease.

174 , and Dec 31, 2015, 13 818 people in England died from liver disease and had large-volume paracentesi

175 BV or HCV infection, only 6 developed HCC or died from liver-related disease.

176 the 1690 HBV carriers developed HCC and 126 died from liver-related diseases.

177 Despite early tumor resection, mice died from locally recurring and distant tumors, but adju

178 to identify those most likely to develop or die from lung cancer.

179 icipants in the T0 negative group would have died from lung cancer (a rise in mortality from 185.82 [

180 ated cells may be due in part to these cells dying from lytic EBV infection when they differentiate a

181 00 to 53% in 2012, many children continue to die from malaria.

182 Each year, over 16,000 patients die from malignant brain cancer in the US.

183 HmWnt-1(R175HmWnt-1) and p53(-/-)mWnt-1 mice died from mammary tumor at the same kinetics, which was

184 le progress in reducing the number of people dying from measles has been made through measles vaccina

185 00 platelets/microL and albuminemia <35 g/L) died from multiorgan failure.

186 we find that 70% of Mef(-/-)Rad50(s/s) mice die from multiple myeloma or other plasma cell neoplasms

187 l graft-versus-host disease, and the patient died from multiple organ failure 4 months after transpla

188 y related to treatment; another patient also died from myocardial infarction related to sepsis.

189 old, a 26-fold, and a 18-fold higher risk of dying from myocardial infarction, heart failure, or stro

190 We have recently demonstrated that RPE cells die from necrosis in response to oxidative stress, provi

191 of brigatinib, including eight patients who died from neoplasm progression.

192 Whereas normoxia-treated KO mice die from neurodegeneration at about 60 d, hypoxia-treate

193 However, only one patient died from NLPHL.

194 ra (P < 0.01); the median age of persons who died from non-AIDS-related causes after age 35 years inc

195 17 (5%) of 370 patients died from non-treatment-related adverse events associate

196 n increase in the proportion of HIV patients dying from non-AIDS-related disorders.

197 rginalised communities have a higher risk of dying from non-communicable diseases (NCDs) than do more

198 Four patients died from nonarrhythmic causes.

199 r survivors of breast cancer will ultimately die from nonbreast cancer-related causes.

200 .5 months, 92 patients were alive, whereas 4 died from noncardiac causes.

201 nt's age, whereas the proportion of patients dying from noncardiac causes, such as cancer, increased.

202 ents had a fatal outcome; of those, 88 (78%) died from nonsurvivable TBI or brain death.

203 Within the study time, 36 patients died from NSCLC and 26 patients from other causes.

204 Likewise, males that would die from ocm mutations can be rescued by reducing the do

205 tion among adoptees whose biological parents died from or were hospitalized for suicidal behavior (BP

206 -45.6%; P = .017), and 8.2% of aspirin users died from other causes (95% CI, 4.6%-13.2%) vs 26.7% of

207 ts, 7,365 died of prostate cancer and 11,811 died from other causes during a median follow-up of 2.8

208 essive disorder and control subjects who had died from other causes.

209 sues among cancer patients and their risk of dying from other causes.

210 n the lifestyle and medical management group died (from pancreatic cancer), thus 119 were included in

211 Whereas no patients died from PBC, the 5-year survival rate was 75%, as comp

212 not seem to significantly affect the risk of dying from PCa.

213 Of these 15 patients, 3 died from persistent infection postoperatively, whereas

214 Lung tissue of patients who had died from pneumococcal pneumonia or a nonpulmonary cause

215 Baboons that received the anti-CD3 rIT died from pneumonia or cardiac failure on days 15 and 23

216 y for signs and symptoms of ischemia, 1 in 5 died from predominantly cardiac pathogeneses within 9 ye

217 Every year, 1.1 million babies die from prematurity, and many survivors are disabled.

218 patients with acute myeloid leukaemia (AML) die from progressive disease after relapse, which is ass

219 e fatty acid intakes were 40% less likely to die from prostate cancer (P(trend) = 0.05 and 0.04, resp

220 d treatment technologies for men unlikely to die from prostate cancer increased from 13% (95% CI, 12%

221 treatment technologies among men unlikely to die from prostate cancer, as assessed by low-risk diseas

222 assigned to radical prostatectomy, 21 (5.8%) died from prostate cancer or treatment, as compared with

223 e disseminated among patients at low risk of dying from prostate cancer is uncertain.

224 ely 30% of patients with soft-tissue sarcoma die from pulmonary metastases.

225 orted exposures to potentially rabid animals died from rabies 18 months after transplantation.

226 Two patients eventually died from radioembolization-induced liver disease.

227 Patients die from recurrent tumors that have become resistant to

228 One patient with congestive heart failure died from refractory left ventricular failure.

229 Several members of a family died from renal failure as a result of systemic amyloido

230 Severely affected babies often die from respiratory insufficiency due to progressive ch

231 ropometric deficits increased the hazards of dying from respiratory tract infections and diarrheal di

232 irst-degree relatives of individuals who had died from SADS.

233 Each year about 400,000 patients die from sepsis, hospital acquired infections, venous th

234 past, and these patients are more likely to die from sepsis.

235 all patients given golimumab in the study, 3 died (from sepsis, tuberculosis, and cardiac failure, al

236 Three infants died from sepsis after random assignment.

237 t 6 months of follow-up except 1 patient who died from sepsis at 1 month.

238 ere uneventful; the patient with single LuTX died from septic multiorgan failure.

239 nts in the memantine group and four controls died from serious adverse events (p=0.77).

240 enness were associated with reduced risks of dying from several common causes of death among urban Ca

241 n this control have been reported in infants dying from SIDS.

242 that could have been saved among persons who died from specific cardiovascular causes by enforcing th

243 rom coronary heart disease (CHD), and 72 men died from stroke.

244 e developing liver, and Gata4-mutant embryos died from subsequent liver hypoplasia and anemia.

245 wo (2%) patients, both in the placebo group, died from sudden cardiac death during follow-up.

246 und at heterozygous state in two infants who died from sudden infant death syndrome (SIDS), one with

247 Each year, almost 1 million people die from suicide, which is among the leading causes of d

248 analysis among all patients with cancer who died from suicide or cardiovascular diseases in the coho

249 ed of 2 or more children in which at least 1 died from suicide.

250 amilies with 2 or more children in which one died from suicide.

251 No patient died from surgery.

252 ular DNA, and mice expressing such receptors died from systemic inflammation and anemia.

253 RNA alterations in hearts from patients who died from systemic sepsis, in comparison to changed mess

254 Organization (WHO), about 1.8 million people die from TB and 10 million new cases are recorded each y

255 cytokine concentrations were more likely to die from TBM.

256 alaria but was uncommon in those who did not die from the disease, a finding that suggests that raise

257 nts with invasive pneumococcal disease (IPD) die from the disease.

258 women will develop melanoma and 10,100 will die from the disease.

259 f oseltamivir initiation were more likely to die from the episode of H5N1 infection than patients who

260 nd prostate cancer (3,811 cases, 511 of whom died from the disease, compared with 2,980 controls-from

261 eveloped tuberculosis and 1.5 million people died from the disease.

262 Carp maintained at 24 degrees C died from the infection, whereas those housed in multi-c

263 ival of many people who would otherwise have died from the initial loss of blood.

264 tive impairment persisted and she eventually died from the sequelae of her disease.

265 Every devil that is 'infected' with DFTD dies from the cancer.

266 d I each have a 50% chance of inheriting and dying from the disorder.

267 tor targets are achieved, the probability of dying from the four main NCDs between the ages of 30 yea

268 r concordant causes of death (i.e., siblings dying from the same causes) but not for discordant cause

269 o increased survival, many MB patients still die from their disease, and patients who survive suffer

270 Most patients with lung cancer still die from their disease, necessitating additional options

271 lf of the patients, while the other patients die from their disease.

272 d patients eventually experience relapse and die from their disease.

273 RECENT FINDINGS: Most adults with AML die from their disease.

274 ical injury, thereby allowing the patient to die from their original disorder.

275 more heart disease, and were more likely to die from their primary liver cancer (all P < 0.0001).

276 mis each independently increased the risk of dying from thin invasive melanoma.

277 ostate cancer, and more than 26,000 men will die from this disease in 2016.

278 the world, and each year thousands of people die from this disease.

279 colon cancer is associated with less risk of dying from this cancer, especially among people who have

280 n's risk estimate in separating patients who died from those who survived at 30 days (c-index, 0.78 v

281 logeneic stem-cell transplantation and later died from transplantation-related complications.

282 Some patients will be cured, others will die from treatment, and some will die of their disease.

283 ed nivolumab 1 mg/kg plus ipilimumab 3 mg/kg died from treatment-related adverse events (myasthenia g

284 vents associated with death, and one patient died from treatment-related adverse events (myositis in

285 g group; four (1%) versus two (<1%) patients died from treatment-related adverse events.

286 11 patients died from treatment-related causes (three in the twice-d

287 Five (2%) patients died from treatment-related causes in the combination gr

288 Five (6%) of 90 patients died from treatment-related causes.

289 ed nivolumab 3 mg/kg plus ipilimumab 1 mg/kg died from treatment-related pneumonitis.

290 ncurrent, one patient; control, one patient) died from treatment-related toxicity.

291 illions of individuals are infected with and die from tuberculosis (TB) each year, and multidrug-resi

292 000-298 000) children younger than 15 years died from tuberculosis worldwide in 2015; 80% (191 000,

293 quently, most patients with advanced disease die from tumor progression.

294 Patients died from tumor progression (55%), cholangitis (18%), pn

295 At the end of follow-up, two patients died from tumor progression, the other 10 patients were

296 mo) after (90)Y TARE, and 41 patients (53%) died from tumor progression.

297 1 tumors and favorable MYC staining patterns died from tumor-related causes.

298 Determination of whether the donor died from undiagnosed rabies and whether other organ rec

299 Of 10 ambulatory patients, 5 died from untreated VF, 4 had cardiac arrests requiring

300 Whether cells dying from viral infection exhibit a cell death-type mod